Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mireya Paulina Velasquez

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Children (Basel, Switzerland)|February 22, 2020
Harnessing T Cells to Target Pediatric Acute Myeloid Leukemia: CARs, BiTEs, and BeyondRebecca Epperly, Stephen Gottschalk, Mireya Paulina Velasquez
Blood|November 10, 2017
Redirecting T cells to hematological malignancies with bispecific antibodiesMireya Paulina Velasquez, Challice L Bonifant, Stephen Gottschalk
Expert Opinion on Biological Therapy|September 26, 2017
Advances in immunotherapy for pediatric acute myeloid leukemiaChallice L Bonifant, Mireya Paulina Velasquez, Stephen Gottschalk
Oncoimmunology|December 3, 2021
Unifying heterogeneous expression data to predict targets for CAR-T cell therapyPatrick Schreiner, Mireya Paulina Velasquez, Stephen Gottschalk, et al.
Cancer Immunology Research|August 20, 2017
CD28 and 41BB Costimulation Enhances the Effector Function of CD19-Specific Engager T CellsMireya Paulina Velasquez, Arpad Szoor, Abishek Vaidya, et al.
Frontiers in Immunology|May 26, 2022
Transgenic Expression of IL15 Retains CD123-Redirected T Cells in a Less Differentiated State Resulting in Improved Anti-AML Activity in Autologous AML PDX ModelsHong Mu-Mosley, Lauren Ostermann, Muharrem Muftuoglu, et al.
Molecular Therapy Oncolytics|September 1, 2017
T Cell-Activating Mesenchymal Stem Cells as a Biotherapeutic for HCCArpad Szoor, Abishek Vaidya, Mireya Paulina Velasquez, et al.
Pediatrics|January 19, 2011
Improving care for children with sickle cell disease/acute chest syndromeElizabeth A Crabtree, M Michele Mariscalco, Joy Hesselgrave, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 13, 2016
CD123-Engager T Cells as a Novel Immunotherapeutic for Acute Myeloid LeukemiaChallice L Bonifant, Arpad Szoor, David Torres, et al.
Scientific Reports|June 4, 2016
T cells expressing CD19-specific Engager Molecules for the Immunotherapy of CD19-positive MalignanciesMireya Paulina Velasquez, David Torres, Kota Iwahori, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Children (Basel, Switzerland)|February 22, 2020
Harnessing T Cells to Target Pediatric Acute Myeloid Leukemia: CARs, BiTEs, and BeyondRebecca Epperly, Stephen Gottschalk, Mireya Paulina Velasquez
Blood|November 10, 2017
Redirecting T cells to hematological malignancies with bispecific antibodiesMireya Paulina Velasquez, Challice L Bonifant, Stephen Gottschalk
Expert Opinion on Biological Therapy|September 26, 2017
Advances in immunotherapy for pediatric acute myeloid leukemiaChallice L Bonifant, Mireya Paulina Velasquez, Stephen Gottschalk
Oncoimmunology|December 3, 2021
Unifying heterogeneous expression data to predict targets for CAR-T cell therapyPatrick Schreiner, Mireya Paulina Velasquez, Stephen Gottschalk, et al.
Cancer Immunology Research|August 20, 2017
CD28 and 41BB Costimulation Enhances the Effector Function of CD19-Specific Engager T CellsMireya Paulina Velasquez, Arpad Szoor, Abishek Vaidya, et al.
Frontiers in Immunology|May 26, 2022
Transgenic Expression of IL15 Retains CD123-Redirected T Cells in a Less Differentiated State Resulting in Improved Anti-AML Activity in Autologous AML PDX ModelsHong Mu-Mosley, Lauren Ostermann, Muharrem Muftuoglu, et al.
Molecular Therapy Oncolytics|September 1, 2017
T Cell-Activating Mesenchymal Stem Cells as a Biotherapeutic for HCCArpad Szoor, Abishek Vaidya, Mireya Paulina Velasquez, et al.
Pediatrics|January 19, 2011
Improving care for children with sickle cell disease/acute chest syndromeElizabeth A Crabtree, M Michele Mariscalco, Joy Hesselgrave, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 13, 2016
CD123-Engager T Cells as a Novel Immunotherapeutic for Acute Myeloid LeukemiaChallice L Bonifant, Arpad Szoor, David Torres, et al.
Scientific Reports|June 4, 2016
T cells expressing CD19-specific Engager Molecules for the Immunotherapy of CD19-positive MalignanciesMireya Paulina Velasquez, David Torres, Kota Iwahori, et al.
Pageof 2